A computational approach to compare microvessel distributions in tumors following antiangiogenic treatmentsRIGHI, Marco; GIACOMINI, Arianna; LAVAZZA, Cristiana et al.Laboratory investigation. 2009, Vol 89, Num 9, pp 1063-1070, issn 0023-6837, 8 p.Article

Targeting TRAIL agonistic receptors for cancer therapyCARLO-STELLA, Carmelo; LAVAZZA, Cristiana; LOCATELLI, Alberta et al.Clinical cancer research. 2007, Vol 13, Num 8, pp 2313-2317, issn 1078-0432, 5 p.Article

Survival in Hodgkin's disease patients : Report of 25 years of experience at the Milan Cancer InstituteBONADONNA, Gianni; VIVIANI, Simonetta; BONFANTE, Valeria et al.European journal of cancer (1990). 2005, Vol 41, Num 7, pp 998-1006, issn 0959-8049, 9 p.Article

MALT lymphoma and Kaposi sarcoma in an HIV-negative patientMIRABILE, Aurora; DEVIZZI, Liliana; GIANNI, Alessandro M et al.American journal of hematology. 2010, Vol 85, Num 10, pp 815-817, issn 0361-8609, 3 p.Article

Serological identification of HSP105 as a novel non-Hodgkin lymphoma therapeutic targetZAPPASODI, Roberta; BONGARZONE, Italia; GIANNI, Alessandro M et al.Blood. 2011, Vol 118, Num 16, pp 4421-4430, issn 0006-4971, 10 p.Article

The anti-human leukocyte antigen-DR monoclonal antibody 1D09C3 activates the mitochondrial cell death pathway and exerts a potent antitumor activity in lymphoma-bearing nonobese diabetic/ severe combined immunodeficient miceCARLO-STELLA, Carmelo; DI NICOLA, Massimo; NAGY, Zoltan et al.Cancer research (Baltimore). 2006, Vol 66, Num 3, pp 1799-1808, issn 0008-5472, 10 p.Article

Early hematopoietic zinc finger protein (EHZF), the human homolog to mouse Evi3, is highly expressed in primitive human hematopoietic cellsBOND, Heather M; MESURACA, Maria; HATA, Akiko et al.Blood. 2004, Vol 103, Num 6, pp 2062-2070, issn 0006-4971, 9 p.Article

ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is PlannedVIVIANI, Simonetta; ZINZANI, Pier Luigi; VALAGUSSA, Pinuccia et al.The New England journal of medicine. 2011, Vol 365, Num 3, pp 203-212, issn 0028-4793, 10 p.Article

Human CD34⁺ cells engineered to express membrane-bound tumor necrosis factor-related apoptosis-inducing ligand target both tumor cells and tumor vasculatureLAVAZZA, Cristiana; CARLO-STELLA, Carmelo; FRANCOLINI, Maura et al.Blood. 2010, Vol 115, Num 11, pp 2231-2240, issn 0006-4971, 10 p.Article

In vivo T-cell immune response against anaplastic lymphoma kinase in patients with anaplastic large cell lymphomasPASSONI, Lorena; GALLO, Barbara; BIGANZOLI, Elia et al.Haematologica (Roma). 2006, Vol 91, Num 1, pp 48-55, issn 0390-6078, 8 p.Article

High response rate and manageable toxicity with an intensive, short-term chemotherapy programme for Burkitt's lymphoma in adultsDI NICOLA, Massimo; CARLO-STELLA, Carmelo; GIANNI, Alessandro M et al.British journal of haematology. 2004, Vol 126, Num 6, pp 815-820, issn 0007-1048, 6 p.Article

Use of recombinant human growth hormone (rhGH) plus recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the mobilization and collection of CD34⁺ cells in poor mobilizersCARLO-STELLA, Carmelo; DI NICOLA, Massimo; CORRADINI, Paolo et al.Blood. 2004, Vol 103, Num 9, pp 3287-3295, issn 0006-4971, 9 p.Article

Phase II study of sorafenib in patients with relapsed or refractory lymphomaGUIDETTI, Anna; CARLO-STELLA, Carmelo; LANOCITA, Rodolfo et al.British journal of haematology. 2012, Vol 158, Num 1, pp 108-119, issn 0007-1048, 12 p.Article

Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease : a pilot study. CommentaryNEELAPU, Sattva S; KWAK, Larry W; BALDASSARI, Paola et al.Blood. 2009, Vol 113, Num 1, issn 0006-4971, 1-2, 18-27 [12 p.]Article

Rituximab Improves the Efficacy of High-Dose Chemotherapy With Autograft for High-Risk Follicular and Diffuse Large B-Cell Lymphoma : A Multicenter Gruppo Italiano Terapie Innnovative nei Linfomi SurveyTARELLA, Corrado; ZANNI, Manuela; CORTELAZZO, Sergio et al.Journal of clinical oncology. 2008, Vol 26, Num 19, pp 3166-3175, issn 0732-183X, 10 p.Article

IFN-γ enhances the antimyeloma activity of the fully human anti-human leukocyte antigen-DR monoclonal antibody 1 D09C3CARLO-STELLA, Carmelo; GUIDETTI, Anna; CORRADINI, Paolo et al.Cancer research (Baltimore). 2007, Vol 67, Num 7, pp 3269-3275, issn 0008-5472, 7 p.Article

Skewed T-cell differentiation in patients with indolent non-Hodgkin lymphoma reversed by ex vivo T-cell culture with γc cytokinesANICHINI, Andrea; MORTARINI, Roberta; ROMAGNOLI, Luca et al.Blood. 2006, Vol 107, Num 2, pp 602-609, issn 0006-4971, 8 p.Article

Dendritic cell viability is decreased after phagocytosis of apoptotic tumor cells induced by staurosporine or vaccinia virus infectionDI NICOLA, Massimo; NAPOLI, Sara; GIANNI, Alessandro M et al.Haematologica (Roma). 2003, Vol 88, Num 12, pp 1396-1404, issn 0390-6078, 9 p.Article

Immunization of patients with malignant melanoma with autologous CD34⁺ cell-derived dendritic cells transduced ex vivo with a recombinant replication-deficient vaccinia vector encoding the human tyrosinase gene: A phase I trialDI NICOLA, Massimo; CARLO-STELLA, Carmelo; CHAPLIN, Paul et al.Human gene therapy. 2003, Vol 14, Num 14, pp 1347-1360, issn 1043-0342, 14 p.Article

The modified International Prognostic Index can predict the outcome of localized primary intestinal lymphoma of both extranodal marginal zone B-cell and diffuse large B-cell histologiesCORTELAZZO, Sergio; ROSSI, Andrea; CHINI, Claudio et al.British journal of haematology. 2002, Vol 118, Num 1, pp 218-228, issn 0007-1048Article

I Role of Apollon in Human Melanoma Resistance to Antitumor Agents That Activate the Intrinsic or the Extrinsic Apoptosis PathwaysTASSI, Elena; ZANON, Marina; CARLO-STELLA, Carmelo et al.Clinical cancer research (Print). 2012, Vol 18, Num 12, pp 3316-3327, issn 1078-0432, 12 p.Article

Risk Factors for the Development of Secondary Malignancy After High-Dose Chemotherapy and Autograft, With or Without Rituximab: A 20-Year Retrospective Follow-Up Study in Patients With LymphomaTARELLA, Corrado; PASSERA, Roberto; CORTELAZZO, Sergio et al.Journal of clinical oncology. 2011, Vol 29, Num 7, pp 814-824, issn 0732-183X, 11 p.Article

Consensus Conference on the use of 90-yttrium-ibritumomab tiuxetan therapy in clinical practice. A project of the Italian Society of HematologyVITOLO, Umberto; BAROSI, Giovanni; FANTI, Stefano et al.American journal of hematology. 2010, Vol 85, Num 2, pp 147-155, issn 0361-8609, 9 p.Article

Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United StatesSANT, Milena; ALLEMANI, Claudia; MAYNADIE, Marc et al.European journal of cancer (1990). 2008, Vol 44, Num 4, pp 579-587, issn 0959-8049, 9 p.Article

The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cellsZAPPASODI, Roberta; DI NICOLA, Massimo; CARLO-STELLA, Carmelo et al.Haematologica (Roma). 2008, Vol 93, Num 10, pp 1523-1534, issn 0390-6078, 12 p.Article